Form 8-K - Current report:
SEC Accession No. 0001104659-24-075711
Filing Date
2024-06-27
Accepted
2024-06-27 16:46:08
Documents
14
Period of Report
2024-06-26
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417504d2_8k.htm   iXBRL 8-K 33325
2 EXHIBIT 4.1 tm2417504d2_ex4-1.htm EX-4.1 8001
  Complete submission text file 0001104659-24-075711.txt   206532

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nbse-20240626.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbse-20240626_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbse-20240626_pre.xml EX-101.PRE 22381
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2417504d2_8k_htm.xml XML 2746
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 241079896
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)